Published in J Exp Med on December 01, 1997
Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis. Circulation (2011) 2.52
Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression. Nat Immunol (2006) 2.37
Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies. PLoS One (2010) 1.73
Enhancement of human immunodeficiency virus type 1 infection by the CC-chemokine RANTES is independent of the mechanism of virus-cell fusion. J Virol (1999) 1.42
A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells. J Exp Med (1999) 1.33
Shikonin, a component of chinese herbal medicine, inhibits chemokine receptor function and suppresses human immunodeficiency virus type 1. Antimicrob Agents Chemother (2003) 1.29
Internalization of CD26 by mannose 6-phosphate/insulin-like growth factor II receptor contributes to T cell activation. Proc Natl Acad Sci U S A (2000) 1.18
Cytokine regulation of human immunodeficiency virus type 1 entry and replication in human monocytes/macrophages through modulation of CCR5 expression. J Virol (1998) 1.16
Modulation of chemokine receptor activity through dimerization and crosstalk. Cell Mol Life Sci (2009) 1.15
Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage. Proc Natl Acad Sci U S A (1998) 1.15
CD26/dipeptidyl peptidase IV regulates prostate cancer metastasis by degrading SDF-1/CXCL12. Clin Exp Metastasis (2008) 1.12
Preoperative serum CD26 levels: diagnostic efficiency and predictive value for colorectal cancer. Br J Cancer (2000) 1.08
Natural proteolytic processing of hemofiltrate CC chemokine 1 generates a potent CC chemokine receptor (CCR)1 and CCR5 agonist with anti-HIV properties. J Exp Med (2000) 1.08
Enhanced inhibition of human immunodeficiency virus type 1 by Met-stromal-derived factor 1beta correlates with down-modulation of CXCR4. J Virol (1999) 1.08
Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy. Nat Immunol (2015) 1.07
CD26 mediates dissociation of Tollip and IRAK-1 from caveolin-1 and induces upregulation of CD86 on antigen-presenting cells. Mol Cell Biol (2005) 1.06
Characterization of the 4C8 antigen involved in transendothelial migration of CD26(hi) T cells after tight adhesion to human umbilical vein endothelial cell monolayers. J Exp Med (1999) 1.02
Rational design of novel HIV-1 entry inhibitors by RANTES engineering. Vaccine (2008) 0.99
Chemokines and chemokine receptors: their role in allergic airway disease. J Clin Immunol (1999) 0.95
Pericellular proteolysis in cancer. Genes Dev (2014) 0.92
HIV infection and pathogenesis: what about chemokines? J Clin Immunol (1999) 0.92
Biochemical analysis of matrix metalloproteinase activation of chemokines CCL15 and CCL23 and increased glycosaminoglycan binding of CCL16. J Biol Chem (2011) 0.92
T-cell activation via CD26 and caveolin-1 in rheumatoid synovium. Mod Rheumatol (2006) 0.92
Chemokine receptors and chemokines in HIV infection. J Clin Immunol (1998) 0.91
Preclinical evaluation of synthetic -2 RANTES as a candidate vaginal microbicide to target CCR5. Antimicrob Agents Chemother (2006) 0.89
Soluble complexes of regulated upon activation, normal T cells expressed and secreted (RANTES) and glycosaminoglycans suppress HIV-1 infection but do not induce Ca(2+) signaling. Proc Natl Acad Sci U S A (1999) 0.89
Molecular mechanisms underlying physiological and receptor pleiotropic effects mediated by GLP-1R activation. Br J Pharmacol (2014) 0.88
Soluble CD26/Dipeptidyl Peptidase IV Enhances the Transcription of IL-6 and TNF-α in THP-1 Cells and Monocytes. PLoS One (2013) 0.88
CD26/dipeptidyl peptidase IV in context. The different roles of a multifunctional ectoenzyme in malignant transformation. J Exp Med (1999) 0.86
Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs. FEBS Open Bio (2013) 0.86
Genetic ablation or pharmacological blockade of dipeptidyl peptidase IV does not impact T cell-dependent immune responses. BMC Immunol (2009) 0.85
Discrimination of agonist and antagonist forms of CXCL10 in biological samples. Clin Exp Immunol (2012) 0.85
Intrapersonal and populational heterogeneity of the chemokine RANTES. Clin Chem (2010) 0.84
Val-boroPro accelerates T cell priming via modulation of dendritic cell trafficking resulting in complete regression of established murine tumors. PLoS One (2013) 0.84
The novel chemokine receptor, G-protein-coupled receptor 75, is expressed by islets and is coupled to stimulation of insulin secretion and improved glucose homeostasis. Diabetologia (2013) 0.83
G1/S cell cycle arrest provoked in human T cells by antibody to CD26. Immunology (2002) 0.81
A T2 cytokine environment may not limit T1 responses in human immunodeficiency virus patients with a favourable response to antiretroviral therapy. Immunology (2006) 0.81
CD26 T cells in the pathogenesis of asthma. Clin Exp Immunol (2005) 0.81
Chemokine (C-C Motif) receptor 1 is required for efficient recruitment of neutrophils during respiratory infection with modified vaccinia virus Ankara. J Virol (2014) 0.81
Increase of CD26/dipeptidyl peptidase IV expression on human gingival fibroblasts upon stimulation with cytokines and bacterial components. Infect Immun (1999) 0.80
The Dipeptidyl Peptidase Family, Prolyl Oligopeptidase, and Prolyl Carboxypeptidase in the Immune System and Inflammatory Disease, Including Atherosclerosis. Front Immunol (2015) 0.80
Multiple roles for chemokines in the pathogenesis of SIV infection. Curr HIV Res (2009) 0.80
Characterization of structure, dynamics, and detergent interactions of the anti-HIV chemokine variant 5P12-RANTES. Biophys J (2013) 0.80
The Role of Dipeptidyl Peptidase - 4 Inhibitors in Diabetic Kidney Disease. Front Immunol (2015) 0.80
Dipeptidyl peptidase 4 promotes epithelial cell transformation and breast tumourigenesis via induction of PIN1 gene expression. Br J Pharmacol (2015) 0.79
Histoplasma capsulatum encodes a dipeptidyl peptidase active against the mammalian immunoregulatory peptide, substance P. PLoS One (2009) 0.79
A novel method for efficient collection of normal mesothelial cells in vivo. J Clin Biochem Nutr (2010) 0.79
Urine proteomes of healthy aging humans reveal extracellular matrix (ECM) alterations and immune system dysfunction. Age (Dordr) (2013) 0.79
Regulation of Chemokine Activity - A Focus on the Role of Dipeptidyl Peptidase IV/CD26. Front Immunol (2016) 0.79
Effect of CD26/dipeptidyl peptidase IV on Jurkat sensitivity to G2/M arrest induced by topoisomerase II inhibitors. Br J Cancer (2003) 0.78
Loss of CD26 protease activity in recipient mice during hematopoietic stem cell transplantation results in improved transplant efficiency. Transfusion (2012) 0.78
Differential Expression and Enzymatic Activity of DPPIV/CD26 Affects Migration Ability of Cervical Carcinoma Cells. PLoS One (2015) 0.78
Transplantation and inflammation: implications for the modification of chemokine function. Immunology (2014) 0.78
CD26/dipeptidyl peptidase IV enhances expression of topoisomerase II alpha and sensitivity to apoptosis induced by topoisomerase II inhibitors. Br J Cancer (2003) 0.77
Quantitative mass spectrometric immunoassay for the chemokine RANTES and its variants. J Proteomics (2014) 0.77
Macrophage colony stimulating factor regulation by nuclear factor kappa B: a relevant pathway in human immunodeficiency virus type 1 infected macrophages. DNA Cell Biol (2011) 0.77
Interaction of human dipeptidyl peptidase IV and human immunodeficiency virus type-1 transcription transactivator in Sf9 cells. Virol J (2010) 0.75
HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science (1996) 26.19
Identification of a major co-receptor for primary isolates of HIV-1. Nature (1996) 23.81
HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature (1996) 20.59
CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science (1996) 18.53
The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell (1996) 17.13
A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell (1996) 14.64
The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature (1996) 11.21
The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature (1996) 9.25
The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol (1994) 6.82
Viral determinants of human immunodeficiency virus type 1 T-cell or macrophage tropism, cytopathogenicity, and CD4 antigen modulation. J Virol (1990) 4.85
Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry (1996) 4.35
Molecular cloning and structure of a pre-B-cell growth-stimulating factor. Proc Natl Acad Sci U S A (1994) 4.25
A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains. J Virol (1996) 3.26
A human T cell-specific molecule is a member of a new gene family. J Immunol (1988) 3.21
Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family. J Exp Med (1992) 2.84
HIV-1 entry and macrophage inflammatory protein-1beta-mediated signaling are independent functions of the chemokine receptor CCR5. J Biol Chem (1997) 2.55
HIV blocked by chemokine antagonist. Nature (1996) 2.50
Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes. J Exp Med (1997) 1.97
Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody. J Immunol (1984) 1.84
Chemokine receptors: structure, function and role in microbial pathogenesis. Cytokine Growth Factor Rev (1996) 1.81
Beta-chemokine inhibition of monocytotropic HIV-1 infection. Interference with a postbinding fusion step. J Immunol (1996) 1.73
High level expression in Chinese hamster ovary cells of soluble forms of CD4 T lymphocyte glycoprotein including glycosylation variants. J Biol Chem (1990) 1.64
Proline specific endo- and exopeptidases. Mol Cell Biochem (1980) 1.64
CD26 expression correlates with entry, replication and cytopathicity of monocytotropic HIV-1 strains in a T-cell line. Nat Med (1995) 1.59
Identification of RANTES receptors on human monocytic cells: competition for binding and desensitization by homologous chemotactic cytokines. J Exp Med (1993) 1.53
The T cell triggering molecule Tp103 is associated with dipeptidyl aminopeptidase IV activity. J Immunol (1990) 1.44
Cloning and functional expression of the T cell activation antigen CD26. J Immunol (1992) 1.40
CD26: a surface protease involved in T-cell activation. Immunol Today (1994) 1.29
RANTES and MCP-3 antagonists bind multiple chemokine receptors. J Biol Chem (1996) 1.27
Deletion of the NH2-terminal residue converts monocyte chemotactic protein 1 from an activator of basophil mediator release to an eosinophil chemoattractant. J Exp Med (1996) 1.12
Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV. Proc Natl Acad Sci U S A (1994) 1.06
Serum high molecular weight dipeptidyl peptidase IV (CD26) is similar to a novel antigen DPPT-L released from activated T cells. J Immunol (1996) 1.05
Identification of the bile canalicular cell surface molecule GP110 as the ectopeptidase dipeptidyl peptidase IV: an analysis by tissue distribution, purification and N-terminal amino acid sequence. Hepatology (1990) 0.95
Are diprotin A (Ile-Pro-Ile) and diprotin B (Val-Pro-Leu) inhibitors or substrates of dipeptidyl peptidase IV? Biochim Biophys Acta (1991) 0.85
Characterization of chemokine proinflammatory proteins by combined liquid chromatography-mass spectrometry. Biochem Soc Trans (1995) 0.79
Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines. Science (1996) 4.39
Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization. J Virol (1994) 3.70
Reproducible high yield sequencing of proteins electrophoretically separated and transferred to an inert support. J Biol Chem (1988) 2.88
Phorbol ester enhances human immunodeficiency virus-promoted gene expression and acts on a repeated 10-base-pair functional enhancer element. Mol Cell Biol (1987) 2.42
Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions. J Virol (1991) 2.40
Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines. AIDS Res Hum Retroviruses (1993) 2.39
Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-gamma of lipopolysaccharide-inducible p35 and p40 genes. Blood (1995) 2.36
Specific antigen-Ia activation of transfected human T cells expressing murine Ti alpha beta-human T3 receptor complexes. Nature (1987) 2.11
Heterogeneity and variation among Neisseria meningitidis lipopolysaccharides. J Bacteriol (1983) 2.01
Inhibition of soluble CD4 therapy by antibodies to HIV. Lancet (1989) 2.01
Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41. J Virol (1995) 1.94
Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis. Hepatology (1999) 1.84
Beta-chemokine inhibition of monocytotropic HIV-1 infection. Interference with a postbinding fusion step. J Immunol (1996) 1.73
Membrane Ia expression and antigen-presenting accessory cell function of L cells transfected with class II major histocompatibility complex genes. J Exp Med (1984) 1.65
CD26 expression correlates with entry, replication and cytopathicity of monocytotropic HIV-1 strains in a T-cell line. Nat Med (1995) 1.59
An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma. Oncogene (2007) 1.57
Isolation and characterization of monkey interphotoreceptor retinoid-binding protein, a unique extracellular matrix component of the retina. Biochemistry (1985) 1.40
Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8. Eur J Biochem (2000) 1.32
Induction of nuclear factor-kappa B and the human immunodeficiency virus long terminal repeat by okadaic acid, a specific inhibitor of phosphatases 1 and 2A. New Biol (1990) 1.28
Qualitative and quantitative studies of antigen-presenting cell function by using I-A-expressing L cells. J Immunol (1985) 1.26
Functional expression of a transfected murine class II MHC gene. Nature (1984) 1.22
Diabetes and nonalcoholic Fatty liver disease: a pathogenic duo. Endocr Rev (2012) 1.18
Cytokine regulation of human immunodeficiency virus type 1 entry and replication in human monocytes/macrophages through modulation of CCR5 expression. J Virol (1998) 1.16
Strain specificity and binding affinity requirements of neutralizing monoclonal antibodies to the C4 domain of gp120 from human immunodeficiency virus type 1. J Virol (1993) 1.16
Cloning and sequencing of the structural gene for the porin protein of Bordetella pertussis. Mol Microbiol (1991) 1.13
Mechanism of Thy-1-mediated T cell activation: roles of Fc receptors, T200, Ia, and H-2 glycoproteins in accessory cell function. J Immunol (1981) 1.12
Regulation of B-cell proliferative responses to lipopolysaccharide by a subclass of thymus T cells. J Exp Med (1977) 1.11
A synaptic basis for T-lymphocyte activation. Ann Immunol (Paris) (1985) 1.11
Molecular pathogenesis of liver disease: an approach to hepatic inflammation, cirrhosis and liver transplant tolerance. Immunol Rev (2000) 1.11
Human Notch-1 inhibits NF-kappa B activity in the nucleus through a direct interaction involving a novel domain. J Immunol (2001) 1.09
Two highly conserved glutamic acid residues in the predicted beta propeller domain of dipeptidyl peptidase IV are required for its enzyme activity. FEBS Lett (1999) 1.09
Transposon-encoded sucrose metabolism in Lactococcus lactis. Purification of sucrose-6-phosphate hydrolase and genetic linkage to N5-(L-1-carboxyethyl)-L-ornithine synthase in strain K1. J Biol Chem (1991) 1.09
Identification of cysteine 354 of beta-tubulin as part of the binding site for the A ring of colchicine. J Biol Chem (1996) 1.08
Regulation of anti-HIV-1 activity of RANTES by heparan sulfate proteoglycans. J Immunol (1997) 1.04
Sheep MHC class II molecules. I. Immunochemical characterization. Immunology (1987) 1.03
Rapid mass spectrometric identification of proteins from two-dimensional polyacrylamide gels after in gel proteolytic digestion. Electrophoresis (1997) 1.03
Role of tyrosine phosphorylation in ligand-independent sequestration of CXCR4 in human primary monocytes-macrophages. J Biol Chem (2001) 1.02
Mapping the binding site of colchicinoids on beta -tubulin. 2-Chloroacetyl-2-demethylthiocolchicine covalently reacts predominantly with cysteine 239 and secondarily with cysteine 354. J Biol Chem (2000) 1.01
Primary structure of rabbit C-reactive protein. J Biol Chem (1982) 0.99
Identification of the cysteine residue of beta-tubulin alkylated by the antimitotic agent 2,4-dichlorobenzyl thiocyanate, facilitated by separation of the protein subunits of tubulin by hydrophobic column chromatography. Biochemistry (1989) 0.99
Stabilzation of pH gradients formed by ampholine. Anal Biochem (1977) 0.98
Purification from Fusobacterium mortiferum ATCC 25557 of a 6-phosphoryl-O-alpha-D-glucopyranosyl:6-phosphoglucohydrolase that hydrolyzes maltose 6-phosphate and related phospho-alpha-D-glucosides. J Bacteriol (1995) 0.97
Regulation of T cell mitogen activity of anti-lymphocyte serum by a B-helper cell. J Immunol (1979) 0.96
Identification of the bile canalicular cell surface molecule GP110 as the ectopeptidase dipeptidyl peptidase IV: an analysis by tissue distribution, purification and N-terminal amino acid sequence. Hepatology (1990) 0.95
Anti-Thy-1-mediated T cell activation. Role of soluble factors and expression of interleukin 2 receptors on T cells. Eur J Immunol (1981) 0.94
Incretin-based therapies--review of the physiology, pharmacology and emerging clinical experience. Intern Med J (2011) 0.93
The Lactococcus lactis triosephosphate isomerase gene, tpi, is monocistronic. Microbiology (1995) 0.91
The predicted structure of the Ia beta 1 domain. A hypothesis for the structural basis of major histocompatibility complex-restricted T-cell recognition of antigens. Scand J Immunol (1985) 0.91
Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection. Liver (2002) 0.91
Antitermination of early transcription in phage HK022. Absence of a phage-encoded antitermination factor. J Mol Biol (1993) 0.89
Identification of human macrophage inflammatory proteins 1alpha and 1beta as a native secreted heterodimer. J Biol Chem (2001) 0.88
Costimulatory properties of the human CD4 molecule: enhancement of CD3-induced T cell activation by human immunodeficiency virus type 1 through viral envelope glycoprotein gp120. AIDS Res Hum Retroviruses (1993) 0.88
Post-proline-cleaving peptidases having DP IV like enzyme activity. Post-proline peptidases. Adv Exp Med Biol (2000) 0.87
Cysticercosis: cellular immune responses during primary and secondary infection. Parasite Immunol (1990) 0.87
Binding to human dipeptidyl peptidase IV by adenosine deaminase and antibodies that inhibit ligand binding involves overlapping, discontinuous sites on a predicted beta propeller domain. Eur J Biochem (1999) 0.86
Inhibition of CCR5 expression by IL-12 through induction of beta-chemokines in human T lymphocytes. J Immunol (1999) 0.86
Contamination of Austrian soil with caesium-137. J Environ Radioact (2001) 0.86
Analysis of HIV-induced autoantibodies to cryptic epitopes on human CD4. J Immunol (1992) 0.85
Sucrose fermentation by Fusobacterium mortiferum ATCC 25557: transport, catabolism, and products. J Bacteriol (1992) 0.85
Purification and characterization of multiple components of human lymphoblastoid interferon-alpha. J Biol Chem (1992) 0.85
Soluble CD26 / dipeptidyl peptidase IV enhances human lymphocyte proliferation in vitro independent of dipeptidyl peptidase enzyme activity and adenosine deaminase binding. Scand J Immunol (2011) 0.85
Aggregation of the high affinity IgE receptor results in the tyrosine phosphorylation of the surface adhesion protein PECAM-1 (CD31). J Biol Chem (1997) 0.84
The amino acid sequence of Limulus C-reactive protein. Evidence of polymorphism. J Biol Chem (1986) 0.84
Mechanisms controlling TCGF production by cloned sublines of EL-4 azgr in response to stimulation by anti-Thy-1 antibody. J Immunol (1982) 0.83
Presence of a distinct CD8+ and CD5- leucocyte subpopulation in the sheep liver. Immunology (1988) 0.83
Lymphocyte subpopulations of sheep in protective immunity to Taenia hydatigena. Parasite Immunol (1989) 0.83
Human immunodeficiency virus type 1 infection of antigen-specific CD4 cytotoxic T lymphocytes. AIDS Res Hum Retroviruses (1998) 0.82
The selective prostaglandin endoperoxide synthase-2 inhibitor, NS-398, reduces prostaglandin production and ovulation in vivo and in vitro in the rat. Biol Reprod (1998) 0.82
Mechanisms of TCGF production by cloned T-cell lines: characterization of producer lymphoma lines and kinetics of production. Clin Immunol Immunopathol (1982) 0.82
Direct photoaffinity labeling of cysteine-295 of alpha-tubulin by guanosine 5'-triphosphate bound in the nonexchangeable site. J Biol Chem (1998) 0.82
Biology of malarial liver stages: implications for vaccine design. Ann Trop Med Parasitol (1998) 0.82
Isolation and characterization of Limulus C-reactive protein genes. J Biol Chem (1986) 0.82
Structural and functional properties of a 69-kilodalton outer membrane protein of Bordetella pertussis. Tokai J Exp Clin Med (1988) 0.81
Direct photoaffinity labeling of cysteine 211 or a nearby amino acid residue of beta-tubulin by guanosine 5'-diphosphate bound in the exchangeable site. J Biol Chem (1999) 0.81
Structure and function of murine class II major histocompatibility complex genes. Mt Sinai J Med (1986) 0.81
Transfected human B lymphoblastoid cells express the mouse Ad beta-chain in association with DR alpha. J Immunol (1986) 0.81
Langerhans cells in the development of skin cancer: a qualitative and quantitative comparison of cell markers in normal, acanthotic and neoplastic ovine skin. Pathology (1997) 0.80
Tumour necrosis factor and interleukin 6 production during interaction between activated CD4+ lymphocytes and simian immunodeficiency virus-infected macrophages. J Gen Virol (1992) 0.80
Lymphocyte subpopulations in the blood of sheep persistently infected with border disease virus. Clin Exp Immunol (1989) 0.79
Electrofocusing in natural pH gradients formed by buffers: gradient modification. Anal Biochem (1977) 0.79
Nonisoelectric focusing in buffers. Anal Biochem (1976) 0.79
The translational hop junction and the 5' transcriptional start site for the Prevotella loescheii adhesin encoded by plaA. Curr Microbiol (1999) 0.78
Isolation, cDNA cloning, and characterization of an 18-kDa hemagglutinin and amebocyte aggregation factor from Limulus polyphemus. J Biol Chem (1992) 0.78
Regulation of TCGF production in T cells. II. Early membrane events after anti-Thy-1 binding by the TCGF-producing T lymphoma EL-4 G-12. J Immunol (1984) 0.78
A three-step method for isolating a few to several hundred milligrams of protein. J Biochem Biophys Methods (1979) 0.78